会員登録
ログイン
【4591】リボミック
創薬。分子標的薬を開発。大株主に大塚製薬。
業績予想修正履歴
| 決算期 | 日付 | 予・実 | 売上高 (百万円) |
対前回 | 修正率 | 修正率 | 営業利益 (百万円) |
対前回 | 修正率 | 修正率 | 経常利益 (百万円) |
対前回 | 修正率 | 修正率 | 当期利益 (百万円) |
対前回 | 修正率 | 修正率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024.03 | 2024/02/13 | Q3予 | - | - | - | - | -1,366 | → | 0.0% | 0.0% | -1,249 | → | 0.0% | 0.0% | -1,250 | → | 0.0% | 0.0% |
| 2024.03 | 2023/11/13 | Q2予 | - | - | - | - | -1,366 | → | 0.0% | 0.0% | -1,249 | → | 0.0% | 0.0% | -1,250 | → | 0.0% | 0.0% |
| 2024.03 | 2023/08/10 | Q1予 | - | - | - | - | -1,366 | → | 0.0% | 0.0% | -1,249 | → | 0.0% | 0.0% | -1,250 | → | 0.0% | 0.0% |
| 2024.03 | 2023/05/12 | 当初予 | - | - | - | - | -1,366 | - | - | - | -1,249 | - | - | - | -1,250 | - | - | - |
| 2023.03 | 2023/05/12 | 実 | 65 | → | 0.0% | 0.0% | -1,786 | ↑ | +25.6% | +25.6% | -1,649 | ↑ | +28.1% | +28.1% | -1,653 | ↑ | +27.9% | +27.9% |
| 2023.03 | 2023/02/10 | Q3予 | 65 | → | 0.0% | 0.0% | -2,402 | → | 0.0% | 0.0% | -2,293 | → | 0.0% | 0.0% | -2,294 | → | 0.0% | 0.0% |
| 2023.03 | 2022/11/11 | Q2予 | 65 | → | 0.0% | 0.0% | -2,402 | → | 0.0% | 0.0% | -2,293 | → | 0.0% | 0.0% | -2,294 | → | 0.0% | 0.0% |
| 2023.03 | 2022/08/09 | Q1予 | 65 | → | 0.0% | 0.0% | -2,402 | → | 0.0% | 0.0% | -2,293 | → | 0.0% | 0.0% | -2,294 | → | 0.0% | 0.0% |
| 2023.03 | 2022/05/13 | 当初予 | 65 | - | - | - | -2,402 | - | - | - | -2,293 | - | - | - | -2,294 | - | - | - |
| 2022.03 | 2022/05/13 | 実 | 80 | → | 0.0% | 0.0% | -1,748 | → | 0.0% | +29.9% | -1,635 | → | 0.0% | +31.6% | -1,684 | → | 0.0% | +29.6% |
| 2022.03 | 2022/05/09 | 修正予 | 80 | → | 0.0% | 0.0% | -1,748 | ↑ | +29.9% | +29.9% | -1,635 | ↑ | +31.6% | +31.6% | -1,684 | ↑ | +29.6% | +29.6% |
| 2022.03 | 2022/02/14 | Q3予 | 80 | → | 0.0% | 0.0% | -2,495 | → | 0.0% | 0.0% | -2,391 | → | 0.0% | 0.0% | -2,393 | → | 0.0% | 0.0% |
| 2022.03 | 2021/11/09 | Q2予 | 80 | → | 0.0% | 0.0% | -2,495 | → | 0.0% | 0.0% | -2,391 | → | 0.0% | 0.0% | -2,393 | → | 0.0% | 0.0% |
| 2022.03 | 2021/08/06 | Q1予 | 80 | → | 0.0% | 0.0% | -2,495 | → | 0.0% | 0.0% | -2,391 | → | 0.0% | 0.0% | -2,393 | → | 0.0% | 0.0% |
| 2022.03 | 2021/05/13 | 当初予 | 80 | - | - | - | -2,495 | - | - | - | -2,391 | - | - | - | -2,393 | - | - | - |
| 2021.03 | 2021/05/13 | 実 | 91 | → | 0.0% | -22.9% | -1,239 | ↑ | +2.7% | +20.6% | -1,184 | ↑ | +2.6% | +20.2% | -1,187 | ↑ | +2.5% | +20.1% |
| 2021.03 | 2021/02/12 | 修正予 | 91 | ↓ | -22.9% | -22.9% | -1,274 | ↑ | +18.4% | +18.4% | -1,216 | ↑ | +18.1% | +18.1% | -1,218 | ↑ | +18.0% | +18.0% |
| 2021.03 | 2020/11/12 | Q2予 | 118 | → | 0.0% | 0.0% | -1,561 | → | 0.0% | 0.0% | -1,484 | → | 0.0% | 0.0% | -1,485 | → | 0.0% | 0.0% |
| 2021.03 | 2020/08/07 | Q1予 | 118 | → | 0.0% | 0.0% | -1,561 | → | 0.0% | 0.0% | -1,484 | → | 0.0% | 0.0% | -1,485 | → | 0.0% | 0.0% |
| 2021.03 | 2020/05/14 | 当初予 | 118 | - | - | - | -1,561 | - | - | - | -1,484 | - | - | - | -1,485 | - | - | - |
| 2020.03 | 2020/05/14 | 実 | 121 | ↑ | +4.3% | +4.3% | -914 | ↑ | +13.4% | +13.4% | -853 | ↑ | +13.6% | +13.6% | -855 | ↑ | +13.5% | +13.5% |
| 2020.03 | 2020/02/07 | Q3予 | 116 | → | 0.0% | 0.0% | -1,055 | → | 0.0% | 0.0% | -987 | → | 0.0% | 0.0% | -988 | → | 0.0% | 0.0% |
| 2020.03 | 2019/11/12 | Q2予 | 116 | → | 0.0% | 0.0% | -1,055 | → | 0.0% | 0.0% | -987 | → | 0.0% | 0.0% | -988 | → | 0.0% | 0.0% |
| 2020.03 | 2019/08/09 | Q1予 | 116 | → | 0.0% | 0.0% | -1,055 | → | 0.0% | 0.0% | -987 | → | 0.0% | 0.0% | -988 | → | 0.0% | 0.0% |
| 2020.03 | 2019/05/14 | 当初予 | 116 | - | - | - | -1,055 | - | - | - | -987 | - | - | - | -988 | - | - | - |
| 2019.03 | 2019/05/14 | 実 | 7 | → | 0.0% | +75.0% | -928 | ↑ | +2.3% | +14.9% | -835 | ↑ | +2.2% | +16.2% | -836 | ↑ | +2.2% | +16.2% |
| 2019.03 | 2019/03/20 | 修正予 | 7 | ↑ | +40.0% | +75.0% | - | - | - | - | -854 | ↑ | +0.4% | +14.3% | -855 | ↑ | +0.3% | +14.3% |
| 2019.03 | 2019/02/13 | Q3予 | 5 | → | 0.0% | +25.0% | -950 | → | 0.0% | +12.8% | -857 | → | 0.0% | +14.0% | -858 | → | 0.0% | +14.0% |
| 2019.03 | 2019/01/28 | 修正予 | 5 | ↑ | +25.0% | +25.0% | -950 | ↑ | +12.8% | +12.8% | -857 | ↑ | +14.0% | +14.0% | -858 | ↑ | +14.0% | +14.0% |
| 2019.03 | 2018/11/13 | Q2予 | 4 | → | 0.0% | 0.0% | -1,090 | → | 0.0% | 0.0% | -997 | → | 0.0% | 0.0% | -998 | → | 0.0% | 0.0% |
| 2019.03 | 2018/08/09 | Q1予 | 4 | → | 0.0% | 0.0% | -1,090 | → | 0.0% | 0.0% | -997 | → | 0.0% | 0.0% | -998 | → | 0.0% | 0.0% |
| 2019.03 | 2018/05/14 | 当初予 | 4 | - | - | - | -1,090 | - | - | - | -997 | - | - | - | -998 | - | - | - |
| 2018.03 | 2018/05/14 | 実 | 64 | ↓ | -1.5% | -1.5% | -899 | ↑ | +10.3% | +10.3% | -751 | ↑ | +14.0% | +14.0% | -753 | ↑ | +13.9% | +13.9% |
| 2018.03 | 2018/02/13 | Q3予 | 65 | → | 0.0% | 0.0% | -1,002 | → | 0.0% | 0.0% | -873 | → | 0.0% | 0.0% | -875 | → | 0.0% | 0.0% |
| 2018.03 | 2017/11/09 | Q2予 | 65 | → | 0.0% | 0.0% | -1,002 | → | 0.0% | 0.0% | -873 | → | 0.0% | 0.0% | -875 | → | 0.0% | 0.0% |
| 2018.03 | 2017/08/08 | Q1予 | 65 | → | 0.0% | 0.0% | -1,002 | → | 0.0% | 0.0% | -873 | → | 0.0% | 0.0% | -875 | → | 0.0% | 0.0% |
| 2018.03 | 2017/05/12 | 当初予 | 65 | - | - | - | -1,002 | - | - | - | -873 | - | - | - | -875 | - | - | - |
| 2017.03 | 2017/05/12 | 実 | 93 | ↓ | -2.1% | -2.1% | -785 | → | 0.0% | 0.0% | -658 | ↑ | +8.5% | +8.5% | -646 | ↑ | +10.3% | +10.3% |
| 2017.03 | 2017/02/13 | Q3予 | 95 | → | 0.0% | 0.0% | -785 | → | 0.0% | 0.0% | -719 | → | 0.0% | 0.0% | -720 | → | 0.0% | 0.0% |
| 2017.03 | 2016/05/12 | 当初予 | 95 | - | - | - | -785 | - | - | - | -719 | - | - | - | -720 | - | - | - |
| 2016.03 | 2016/05/12 | 実 | 121 | ↑ | +1.7% | -76.9% | -532 | ↓ | -12.2% | -343.3% | -322 | ↑ | +28.6% | -274.4% | -323 | ↑ | +28.5% | -236.5% |
| 2016.03 | 2016/02/09 | Q3予 | 119 | ↑ | - | -77.3% | -474 | ↓ | -295.0% | -295.0% | -451 | ↓ | - | -424.4% | -452 | ↓ | - | -370.8% |
| 2016.03 | 2015/11/06 | Q2予 | 0 | ↓ | -100.0% | -100.0% | - | - | - | - | 0 | ↑ | +100.0% | +100.0% | 0 | ↑ | +100.0% | +100.0% |
| 2016.03 | 2015/08/13 | Q1予 | 524 | → | 0.0% | 0.0% | -120 | → | 0.0% | 0.0% | -86 | → | 0.0% | 0.0% | -96 | → | 0.0% | 0.0% |
| 2016.03 | 2015/05/14 | 当初予 | 524 | - | - | - | -120 | - | - | - | -86 | - | - | - | -96 | - | - | - |
| 2015.03 | 2015/05/14 | 実 | 479 | ↓ | -5.7% | -5.7% | 6 | ↓ | -81.3% | -81.3% | 13 | ↓ | -74.0% | -74.0% | 10 | ↓ | -77.8% | -77.8% |
| 2015.03 | 2015/02/09 | Q3予 | 508 | → | 0.0% | 0.0% | 32 | → | 0.0% | 0.0% | 50 | → | 0.0% | 0.0% | 45 | → | 0.0% | 0.0% |
| 2015.03 | 2014/11/07 | 当初予 | 508 | - | - | - | 32 | - | - | - | 50 | - | - | - | 45 | - | - | - |
